Cytopharma is the first pharmaceutical company in Africa & Middle East region that is fully dedicated to the manufacturing and marketing of generic cytotoxic drugs.
We care about your patients
Established in Tunisia since 2011, Cytopharma's purpose is to provide high quality and affordable oncology medicine for cancer patients all over the world, helping them successfully fighting the disease.
Cytopharma has a production line of injectable oncology products in both liquid and lyophilized forms.
Our steadily growing product portfolio is currently counting five molecules :
Fluorouracil (5-FU) - 250, 500 and 1000 mg
Oxaliplatin - 50 and 100 mg
Epirubicin - 10 and 50 mg
Paclitaxel - 30, 100 and 150 mg
Docetaxel - 20 and 80 mg
As we are expanding our business towards Africa, Middle East and Europe, we are open to any kind of partnership : distribution, contract manufacturing, co-promotion, co-marketing ...
